Disease Info Card

Cebpa Gene Mutation

Information about Cebpa Gene Mutation: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Cebpa Gene Mutation

Most recent studies have shown that Cebpa Gene Mutation shares some biological mechanisms with acute-leukemia, acute-myeloid-leukemia-m1, adult-acute-myeloblastic-leukemia, chromosomal-translocation, clonal-evolution, cytogenetic-abnormality, endometrial-polyp, flt3-internal-tandem-duplication, leukemia, leukemia-myelocytic-acute, leukemogenesis, malignant-neoplasms, monosomy, mutation-out-of-frame, myeloid-leukemia, myeloid-neoplasm, myelomonocytic-leukemia, neoplasms, npm1-gene-mutation, secondary-acute-myeloid-leukemia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Cebpa Gene Mutation, and have been seen in publications frequently: Cell Differentiation, Cell Proliferation, Dna Hypermethylation, Granulocyte Differentiation, Methylation, Mitotic Recombination, Myeloid Cell Differentiation, Translation

Quite a number of genes have been found to play important roles in Cebpa Gene Mutation, such as ABL1, ANPEP, CCND3, CD33, CD34, CD7, CEBPA, FANCB, FLT3, INVS, KIT, LMLN, MID1, NPM1, RUNX1, SFRP1, SFRP5, UGP2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.